Metabolic Dysfunction-Associated Steatohepatitis (MASH) Symptoms

When it first develops, MASH often has no symptoms or may only cause general fatigue or discomfort in the abdomen. If the condition progresses, however, its symptoms — such as itching, swelling, excessive bruising, and muscle wasting — will accumulate and become more serious.
Symptoms of MASH
- Persistent fatigue, or feeling tired consistently
- Discomfort or pain in the upper right abdomen where your liver sits
- Unexplained weight loss
- Weakness or general malaise
- Pruritus, or intense itching
- Ascites, or swelling in the abdomen from fluid buildup
- Edema, a swelling in the legs
- Jaundice, a yellowing of the skin and eyes
- Bruising and bleeding easily
- Spider angiomas, or blood vessels just under the surface of your skin that look like a spiderweb
- Hepatic encephalopathy, or a buildup of blood toxins that can cause behavior changes, slurred speech, and confusion
- Red palms
- Shortness of breath
- Internal bleeding
- Muscle wasting
- Portal hypertension, or increased pressure in the portal vein that causes the liver and spleen to enlarge
.png?sfvrsn=28de4010_3)
Stages of MASH
MASH doesn’t appear overnight. It evolves over time as part of MASLD, which is defined by a buildup of unhealthy fat within your liver. The stage of MASH you have depends on how much liver scarring, or fibrosis, you have.
The stages of MASH describe increasing levels of liver damage:
- Stage 1: MASH with mild fibrosis indicates an early level of liver scarring that can often be reversed with self-care.
- Stage 2: In MASH with moderate fibrosis, inflammation and cellular damage have caused some liver scarring that could be reversed. Your liver is still working well.
- Stage 3: MASH with advanced fibrosis includes extensive liver scarring. Some of this damage can be reversed. But at this stage, treatment from healthcare professionals is necessary to prevent further, permanent damage and maintain your liver function.
- Stage 4: When cirrhosis sets in at this stage, scarring is severe enough to change your liver’s shape. Some of the scarring is permanent, but some damage may still be reversible. Your liver may still function at a reduced capacity, but liver cancer and failure are serious risks.
Potential Complications of MASH
- Coronary artery disease
- Atherosclerosis, a buildup of plaque in the arteries
- Changes in heart size and shape
- Heart failure
- Arrhythmia, or irregular heartbeat
- Muscular atrophy, in which your muscles progressively weaken and degenerate
- Sarcopenia, a loss of muscle mass and function
- Inflammatory myopathies, rare muscle disorders that include skeletal muscle inflammation
When to See a Doctor
Because MASH symptoms can be vague or nonexistent in early stages, it can be difficult to know if you have MASH before it becomes a serious issue.
- Jaundice
- Easy bruising
- Dark urine
- Swelling in the abdomen or legs
- Vomiting blood
- Dark or black tarry feces
- Periods of confusion, mood changes, forgetfulness, or poor judgment
- Unexplained skin itching
The Takeaway
- MASH is a progressive and potentially serious liver condition, but it may not present symptoms until damage is advanced.
- Early MASH may include fatigue, pain in the upper right abdomen, weakness, and unexplained weight loss.
- The earlier MASH is detected, the more likely you can halt or even reverse the damage to your liver.
- Left untreated, MASH can lead to serious complications such as liver failure and liver cancer, cardiovascular disease and other heart issues, and muscular issues.
Resources We Trust
- Mayo Clinic: Have You Checked Up on Your Liver? Diagnosing MASH and Steatotic Liver Disease
- Cleveland Clinic: Diet Changes and Food to Help Manage MASH
- American Liver Foundation: Tips on How to Take Care of Your Liver
- British Liver Trust: Worried About Your Liver?
- UPMC HealthBeat: Why Is Exercise Important for Liver Disease Patients?
- Metabolic Dysfunction-Associated Steatohepatitis (MASH). Cleveland Clinic. May 5, 2025.
- Corliss J. An often-silent liver condition that threatens the heart. Harvard Health Publishing. January 1, 2025.
- Nonalcoholic Fatty Liver Disease. Johns Hopkins Medicine.
- Metabolic Dysfunction-Associated Steatohepatitis (MASH) Symptoms. Stanford Medicine.
- MASLD and MASH* Symptoms. American Liver Foundation. June 12, 2025.
- Hepatic Encephalopathy. American Liver Foundation. July 20, 2022.
- Nonalcoholic Fatty Liver Disease. Mayo Clinic. April 4, 2024.
- Portal Hypertension. UCLA Health.
- MASLD, NAFLD and fatty liver disease. British Liver Trust.
- Zheng J et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Nature. February 7, 2025.
- MASH Complications. American Liver Foundation. April 2025.
- End-Stage Liver Disease. American Liver Foundation. June 12, 2025.
- Heptocellular Carcinoma (HCC). Cleveland Clinic. February 13, 2025.
- Liver Failure. Cleveland Clinic. June 14, 2024.
- Sandireddy R et al. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Frontiers in Cell and Developmental Biology. July 16, 2024.
- Sanyal AJ et al. Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review. American Heart Journal Plus. March 24, 2024.

Michelle Seguin, MD
Medical Reviewer
Michelle Seguin, MD, is a board-certified family medicine, lifestyle medicine, and certified functional medicine physician (IFMCP). She is a practicing physician at Root Functional Medicine, a leading telemedicine practice specializing in personalized, root-cause care.

Joseph Bennington-Castro
Author
Joseph Bennington-Castro is a science writer based in Hawaii. He has written well over a thousand articles for the general public on a wide range topics, including health, astronomy, archaeology, renewable energy, biomaterials, conservation, history, animal behavior, artificial intelligence, and many others.
In addition to writing for Everyday Health, Bennington-Castro has also written for publications such as Scientific American, National Geographic online, USA Today, Materials Research Society, Wired UK, Men's Journal, Live Science, Space.com, NBC News Mach, NOAA Fisheries, io9.com, and Discover.